iShares Biotechnology ETF (NQ:IBB)

If the newfound support and uptrend in the biotech sector last, as the new year quickly approaches, the biotech sector could shift from lagger to leader.

Topics Economy

3 biotech powerhouses poised to thrive amid sector rebound

December 08, 2023

The recent reversal and reclaim of the significant $124 support level in the IBB holds importance, indicating a potential shift in momentum.

Topics ETFs

Biotech reversal confirmed: what's ahead for the IBB?

December 08, 2023

We are having a great but choppy market recovery over the past four weeks and it looks like it should continue through to the next earnings cycle in January.

Topics ETFs

Biotech And Healthcare Portfolio Playbook For December 2023/24 ↗

November 27, 2023

Many successful blockbusters started with a small trial. But you should temper your expectations until a larger, more rigorous trial is conducted.

Three Lessons For Investing In Biotech Companies ↗

August 23, 2023

ETFs have not helped as portfolio fillers but they can identify trends. We should play this rally out of a biotech bear market.

Are You A Trader Or Investor: Biotech Momentum Is Picking Up ↗

November 20, 2023

If you invest over the long term, you'll increase your chances of victory.

Topics ETFs

You Don't Have to Pick a Winner in Biotech. Here's Why. ↗

November 18, 2023

Via The Motley Fool

Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures ↗

November 09, 2023

Unveil the resilience of biotech stocks as they outsmart market trends and champion the race for tomorrow's treatments.

Market Bubbles may take a long time to clear and we created a big one in July 2021 dealing with the COVID pandemic.

Healthcare Playbook: Hardly Defensive With A Covid Hangover In Biotech ↗

November 01, 2023

Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield... ↗

October 23, 2023

The upcoming quarter GDP is expected to hit 3.7% which has brought the FED dialogue to “higher rates for longer” which might lead us to a recession in 2024. So watch the yield on the 10-year TSY now at...

As far as the market goes, it feels like time is standing still.

Topics Economy

When News Moves So Fast, Stocks Can Stand Still ↗

October 16, 2023

Conservative investors buy Johnson & Johnson for the dividend, but that payout is less safe after its Kenvue spinoff

Johnson & Johnson Stock: Is Now the Time to Sell? ↗

October 14, 2023

Large Cap Biopharmaceuticals-Core Holdings For Your Healthcare Portfolio Until M&A Action Picks Up ↗

October 09, 2023

Healthcare has not been a strong sector in 2023. Despite its history of being defensive in turbulent times the sector has underperformed as higher rates curb buyers sentiment.

As long as the S&P 500 outperforms long bonds (TLT) risk is on.

Fresh Look At Long Bonds ↗

September 14, 2023

Despite concerns about rising healthcare costs and ever more expensive technology for treatment encompassing drugs, devices, and data management, still innovative medicine marches on.

Topics Bonds Stocks

Healthcare Playbook Revisited - Growth Plus Value ↗

September 13, 2023

Gilead Sciences has underperformed the broader market this year by a hefty margin.

Time For Gilead Sciences-Heavy ETFs? ↗

September 12, 2023

The QQQ chart right now has a few key aspects.

Technical Correction Or Return Of The Bear Market? ↗

September 06, 2023

Should XRT break the July calendar range low, we will once again be talking about the 80-month moving average or the 6–7-year business cycle low.

It’s Really All About the Retail Sector Now ↗

September 05, 2023

With the biotech sector looking poised to continue its rally further, investors would do well to buy these stocks to capitalize.

The 3 Best Biotech Stocks to Buy Now: September 2023 ↗

September 04, 2023

It is important to track sectors of the market because trends to create volatility. For example the COVID pandemic created a diagnostics and vaccine revenue bubble that dissipated over several months.

Industry ETFs In The Spotlight: Winners And Losers Of The Month Revealed ↗

August 31, 2023

Via Benzinga

Topics ETFs

Life Science Mutual Funds Compared To ETFs And What Is In Your Portfolio? ↗

August 30, 2023

At a time when the world is experiencing de-globalization, an alliance of countries including Brazil, Russia, China, South Africa and possibly India is a potential threat to the west.

Topics ETFs

BRICS And The Recent Headline ↗

August 23, 2023

With BRICS happening ahead of Jackson Hole, it would be good to look at the technical charts on both the dollar and the long bonds.

The US Dollar And Long Bonds Doing The Dosey Doe ↗

August 22, 2023

As we move into September, the MarketMaster AI is flashing warning signals about risky equities. Sell these meme stocks right now.

5 Meme Stocks to Sell Immediately, According to AI ↗

August 22, 2023

Biotechnology has traded basically sideways since the start of 2023.

Topics Artificial Intelligence

Biotechnology On Drugs ↗

August 21, 2023

Large Cap Biopharmaceuticals Performance 2023 YTD: Mixed Results But Lilly Is A Big Winner ↗

August 21, 2023

Biotech stocks are in a bear market since the IBB hit $177.37 in 2021 and is down 7.84% over five years.

As the IBB ETF nears a potential breakout, watch for strong performers like Regeneron Pharmaceuticals, Vertex, and Exelixis to continue outperforming.

3 Strong Biotech Performers To Watch As Sector Nears Breakout

August 17, 2023

This article points you to three undervalued biotech stocks that have the potential to deliver stellar returns for patient investors.

Topics ETFs

The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023 ↗

August 17, 2023

Weight-Loss Drug Wegovy Adds Mass To Novo Nordisk's stock, Pushing Valuation Past Denmark's GDP ↗

August 12, 2023

Via Benzinga

CPI-Market Impact Now And Later? ↗

August 10, 2023

A discussion about inflation, bonds, calendar ranges, and places to park your money